光动力疗法治疗脉络膜新生血管性疾病后导致的脉络膜低灌注  

Choroidai hypoperfusion associated with photodynamic therapy for choroidal neovascularization

作　　者：杜军辉 李蓉[2] 

机构地区：[1]西安市第九医院眼科,710054 [2]第四军医大学西京医院眼科全军眼科研究所,西安710032

出　　处：《中华实验眼科杂志》2013年第8期788-791,共4页Chinese Journal Of Experimental Ophthalmology

摘　　要：脉络膜新生血管（CNV）是引起多种眼底疾病视力障碍的主要原因。目前临床上有多种治疗方法，如光动力疗法（PDT）、抗血管内皮生长因子（VEGF）疗法、经瞳孔温热疗法（TTT）等，但都不能彻底治愈CNV，需要重复多次治疗。其中，PDT能特异性封闭CNV，但可引起脉络膜低灌注。就PDT治疗后产生的脉络膜低灌注及其影响和应对措施进行综述，回顾PDT治疗后发生脉络膜低灌注的证据，与临床效果之间的关系，评估联合治疗的作用，讨论使用低照度光动力激光治疗减少低灌注的潜力。Choroidal neovascularization （CNV） ithe leading cause of vision disordecaused by variouretinal diseases.Apresent,many therapeutimethodare employed clinically,such aphotodynamitherapy （PDT）,anti-vasculaendothelial growth facto（anti-VEGF） and transpupillary thermotherapy （TTT）.However,none of them can cure CNV thoroughly and repeated treatmenirequired usually.The reason forecurrenCNV istill unclear.Choroidal hypoperfusion associated with Pdmay be one of the reasons.The purpose of thireview ito discusthe problem of choroidal hypoperfusion associated with PDfoCNV awell aitimpacon the eye and possible solutions.Thipapepresentevidenceof choroidal hypoperfusion aftePDand itrelationship with clinical outcomes.Meanwhile,the effecof combination therapy iassessed.Finally,low-fluence Pdirecommended apotential method to reduce choroidal hypoperfusion.

关 键 词：光动力疗法 脉络膜新生血管 脉络膜低灌注 

分 类 号：R773[医药卫生—眼科]